These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31292326)

  • 1. Polymorphism in Organic Anion-Transporting Polypeptide Gene Related to Methotrexate Response in Rheumatoid Arthritis Treatment.
    Takahashi K; Nakamura H; Watanabe A; Majima T; Koiwa M; Kamada T; Takai S
    J Nippon Med Sch; 2019; 86(3):149-158. PubMed ID: 31292326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single nucleotide polymorphism of reduced folate carrier 1 predicts methotrexate efficacy in Japanese patients with rheumatoid arthritis.
    Hayashi H; Tazoe Y; Tsuboi S; Horino M; Morishita M; Arai T; Ohshima M; Matsuyama T; Kosuge K; Yamada H; Tsuji D; Inoue K; Itoh K
    Drug Metab Pharmacokinet; 2013; 28(2):164-8. PubMed ID: 22971639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
    Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
    Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between SLCO1A2 genetic variation and methotrexate toxicity in human rheumatoid arthritis treatment.
    Wang J; Yin J; Li W; Xiao C; Han J; Zhou F
    J Biochem Mol Toxicol; 2020 Aug; 34(8):e22513. PubMed ID: 32304147
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sundbaum JK; Baecklund E; Eriksson N; Hallberg P; Kohnke H; Wadelius M
    Pharmacogenomics; 2020 Apr; 21(5):337-346. PubMed ID: 32024416
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced folate carrier-1 80G > A gene polymorphism is not associated with methotrexate treatment response in South Indian Tamils with rheumatoid arthritis.
    Muralidharan N; Mariaselvam CM; Mithun CB; Negi VS
    Clin Rheumatol; 2016 Apr; 35(4):879-85. PubMed ID: 25771854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
    Takatori R; Takahashi KA; Tokunaga D; Hojo T; Fujioka M; Asano T; Hirata T; Kawahito Y; Satomi Y; Nishino H; Tanaka T; Hirota Y; Kubo T
    Clin Exp Rheumatol; 2006; 24(5):546-54. PubMed ID: 17181924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Predicting the Therapeutic Response to Methotrexate in Japanese Patients with Rheumatoid Arthritis: A Hospital-Based Cohort Study.
    Hakamata J; Kaneko Y; Shimizu M; Yamaoka K; Maruyama J; Takeuchi T; Mochizuki M; Hashiguchi M
    Biol Pharm Bull; 2018; 41(9):1414-1422. PubMed ID: 30175777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.
    Hughes LB; Beasley TM; Patel H; Tiwari HK; Morgan SL; Baggott JE; Saag KG; McNicholl J; Moreland LW; Alarcón GS; Bridges SL
    Ann Rheum Dis; 2006 Sep; 65(9):1213-8. PubMed ID: 16439441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
    Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
    Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
    Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients.
    Lima A; Seabra V; Bernardes M; Azevedo R; Sousa H; Medeiros R
    PLoS One; 2014; 9(10):e108165. PubMed ID: 25279663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis.
    Shao W; Yuan Y; Li Y
    Genet Test Mol Biomarkers; 2017 May; 21(5):275-285. PubMed ID: 28277784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis.
    Li X; Hu M; Li W; Gu L; Chen M; Ding H; Vanarsa K; Du Y
    Int Immunopharmacol; 2016 Sep; 38():8-15. PubMed ID: 27233001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients.
    Wang Z; Zhang N; Chen C; Chen S; Xu J; Zhou Y; Zhao X; Cui Y
    Curr Drug Metab; 2019; 20(7):592-600. PubMed ID: 31267867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study.
    Melikoglu MA; Balkan E
    Inflammopharmacology; 2022 Feb; 30(1):193-197. PubMed ID: 35043269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
    Lima A; Bernardes M; Azevedo R; Medeiros R; Seabra V
    Int J Mol Sci; 2015 Jun; 16(6):13760-80. PubMed ID: 26086825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
    Plaza-Plaza JC; Aguilera M; Cañadas-Garre M; Chemello C; González-Utrilla A; Faus Dader MJ; Calleja MA
    OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
    Scand J Rheumatol; 2021 May; 50(3):213-217. PubMed ID: 33025831
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis : A meta-analysis.
    Lee YH; Bae SC; Song GG
    Z Rheumatol; 2016 Sep; 75(7):707-15. PubMed ID: 26184955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.